Aerovate Therapeutics, Inc.
News
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Receives Average Recommendation of "Hold" from Analysts
Ticker Report Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE - Get Free Report) have earned a consensus recommendation of "Hold" from the six brokerages that are covering the company, Marketbeat.com reports...\n more…
SG Americas Securities LLC Buys Shares of 179,493 Aerovate Therapeutics, Inc. (NASDAQ:AVTE)
Ticker Report SG Americas Securities LLC purchased a new position in shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE - Free Report) in the second quarter, according to the company in its most recent disclosure...\n more…
Values First Advisors Inc. Purchases Shares of 15,381 Aerovate Therapeutics, Inc. (NASDAQ:AVTE)
Ticker Report Values First Advisors Inc. acquired a new position in shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing...\n more…
Q3 2024 Earnings Forecast for Aerovate Therapeutics, Inc. Issued By Wedbush (NASDAQ:AVTE)
Ticker Report Aerovate Therapeutics, Inc. (NASDAQ:AVTE - Free Report) - Research analysts at Wedbush boosted their Q3 2024 earnings per share estimates for Aerovate Therapeutics in a report issued on Tuesday...\n more…
Wedbush Weighs in on Aerovate Therapeutics, Inc.'s FY2028 Earnings (NASDAQ:AVTE)
Ticker Report Aerovate Therapeutics, Inc. (NASDAQ:AVTE - Free Report) - Investment analysts at Wedbush issued their FY2028 EPS estimates for Aerovate Therapeutics in a note issued to investors on Tuesday, August...\n more…